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1 What Lies Beneath: Exploring Specific Depressive Symptoms across Selected Risk 
2 Factors in Icelandic Team Sport Athletes
3
4 Abstract: The aim of the study was to explore the prevalence of specific symptoms of 
5 depression in athletes, and to test differences in the likelihood of exhibiting these symptoms 
6 across age, sex, type of team sport, and level of competition. A sample of Icelandic male and 
7 female team sport athletes (N=894, 18-42 years) were included in the study. Of the athletes 
8 exhibiting clinically significant depressive symptoms on the Patient Health Questionnaire 
9 (PHQ-9), 37.5% did not exhibit core symptoms of depression. Compared to males, females 
10 were significantly more likely to exhibit depressed mood, feelings of worthlessness/guilt, 
11 problems with sleep, fatigue, appetite, and concentration. Within males, differences were 
12 mostly related to neurovegetative aspects of depression (sleep and appetite), whereas in 
13 females, differences were related to cognitive/emotional aspects (e.g. depressed mood, 
14 guilt/worthlessness). The findings underline the importance of exploring specific symptoms of 
15 depression to provide a richer understanding of depressive symptomology in athletes. 
16 Keywords: Patient Health Questionnaire, Screening, Prevalence, Sex differences, 
17 assessment
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18 Within the past decade, depression-related research in athletes has aimed at establishing 
19 an improved understanding of athletes’ susceptibility to depression and depressive symptoms 
20 (Golding et al., 2020; Gorczynski et al., 2017; Wolanin et al., 2015). There is now an 
21 empirically grounded consensus that athletes are a unique population challenged by a range of 
22 generic and sport-specific stressors (Küttel & Larsen, 2019; Reardon et al., 2019; Wolanin et 
23 al., 2015), and that prevalence rates of depressive symptoms in athletes may be 
24 comparable to those observed in the general population (Gorczynski et al., 2017; Junge & 
25 Feddermann-Demont, 2016; Nixdorf et al., 2013; Wolanin et al., 2016). As reported in a  
26 recent review by Golding et al. (2020), depressive symptom prevalence has ranged from 
27 6.7% to 34.0% across athlete samples, and that several demographic risk factors such as 
28 sex, level of competition, and type of sport have been linked with elevated depressive 
29 symptoms in this population. Similar to research on normative sex differences (Breslau et 
30 al., 2017; Hankin et al., 1998), female athletes have shown to report higher levels of 
31 depressive symptoms than male athletes (Gorczynski et al., 2017; Wolanin et al., 2015). It has 
32 also been suggested that athletes competing at lower levels exhibit higher prevalence of 
33 depressive symptoms than those competing at higher levels (Junge & Prinz, 2018; Nixdorf et 
34 al., 2013). However, younger age has also shown to correlate with elevated depressive 
35 symptoms in athletes (Beable et al., 2017), and it is therefore uncertain whether the observed 
36 difference between higher- and lower-level athletes is due to the level of competition per-se, or 
37 whether this relationship is better explained by potential age-effects. Recent evidence also 
38 shows that susceptibility to depression and depressive symptoms may vary across 
39 different types of sports (Schaal et al., 2011; Wolanin et al., 2016). However, as discussed 
40 by several authors (e.g. Nixdorf et al., 2013; Tahtinen et al., 2020; Wolanin et al., 2016), 
41 samples have often consisted of a relatively small number of athletes across different 
42 sports, and therefore, comparisons have tended to focus on differences between broader 
43 sport categories such as team and individual sports (e.g. Beable et al., 2017; Nixdorf et al., 
44 2013). Consequently, to better understand potential sport-specific differences, scholars 
Page 2 of 37
http://mc.manuscriptcentral.com/hk_jcsp
Journal of Clinical Sport Psychology
For Peer Review
45 have underlined that future studies should aim to include larger samples across specific 
46 sports (Golding et al., 2020; Junge & Feddermann-Demont, 2016; Junge & Prinz, 2018; 
47 Nixdorf et al., 2013; Wolanin et al., 2016). 
48 While the evidence-base on various depression-related topics in athletes has been 
49 growing rapidly, less attention has, however, been paid to the heterogeneous subset of 
50 symptoms that underlie the construct of depression itself (Ringland, 2016; Schuch, 2015), and 
51 the potential implications this heterogeneity may have on the interpretation and dissemination 
52 of research findings (Golding et al., 2020; Schuch, 2015). Therefore, we will shortly discuss 
53 the definition and assessment of depression, and how the current study aims to address these 
54 issues. 
55 According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; 
56 American Psychiatric Association, 2013), major depressive disorder (MDD) is defined as 
57 consisting of nine potential symptoms; depressed mood, decreased interest or pleasure 
58 (anhedonia), changes in weight or appetite, problems with sleep, psychomotor agitation or 
59 retardation, fatigue/loss of energy, worthlessness/guilt, problems with concentration, and 
60 thoughts of death. MDD is diagnosed by structured or semi-structured clinical interviews, 
61 and to receive a diagnosis, individuals must exhibit five (or more) depressive symptoms of 
62 which at least one must be depressed mood or decreased interest/pleasure (American 
63 Psychiatric Association, 2013). Considering that depressed mood or decreased 
64 interest/pleasure is the only specified symptom required for a diagnosis, the symptom 
65 presentation across individuals diagnosed with MDD can be highly heterogeneous (individuals 
66 exhibit different types of symptoms) (Zimmerman et al., 2015). There are, in fact “…roughly 
67 1,000 unique combinations of symptoms that all qualify for a diagnosis of MDD, some of 
68 which do not share a single symptom” (Fried & Nesse, 2015, p.2). 
69 Depression can also be assessed via self-report questionnaires in which the overall 
70 symptom severity, rather than a formal diagnosis, is the main outcome measure (Fried & 
71 Nesse, 2015b; Ingram et al., 2015). Questionnaires can vary in terms of their assessment period 
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72 (e.g. symptoms present the past week or past two weeks), and the number and type of 
73 symptoms assessed. For example, the Center for Epidemiologic Studies Depression Scale 
74 (CES-D, Radloff, 1977) is a 20-item questionnaire, and assesses the presence of both 
75 positive and negative affect items in the past week. Another commonly utilized self-report 
76 measure (Golding et al., 2020; Trojian, 2016) is the nine-item Patient Health Questionnaire 
77 (PHQ-9, Kroenke & Spitzer, 2002), which is specifically designed to assess the presence of 
78 the nine depressive symptoms listed in DSM over the past two weeks. Despite the structural 
79 differences of depression questionnaires or screening tools, a common feature is that the 
80 overall symptom severity is calculated by summing scores from individual symptom items. 
81 Specified cut-off points are then imposed to indicate the clinical significance of symptom 
82 severity, that is, whether the summed scores reach severity levels that may call for intervention 
83 or further assessment (Kroenke & Spitzer, 2002; Radloff, 1977). However, when summed 
84 symptom scores are utilized to determine clinical significance, there is no criteria for the 
85 type or number of symptoms that must be present (Fried et al., 2016). Consequently, the 
86 symptom heterogeneity discussed concerning MDD is further escalated when depression is 
87 operationalised in terms of summed symptom scores (Fried et al., 2016).
88 While questionnaires have been the most common method of assessment in depression-
89 related research in athletes (Golding et al., 2020), studies sometimes identify this method as 
90 a limitation of their study - highlighting that questionnaires do not provide a diagnosis of 
91 depression (e.g. Beable et al., 2017; Weber et al., 2018). However, if questionnaires are 
92 not designed to diagnose depression (Levis et al., 2020), then identifying them as a 
93 limitation in this context may convey a paradoxical message - implicitly suggesting that, 
94 in essence, the objective of the research is to estimate the prevalence of MDD. When this is 
95 coupled with the interchangeable use of terms depression and depressive symptoms, there is an 
96 increased risk that sum-scores on questionnaires become interpreted as a proxy for MDD 
97 (Schuch, 2015). This would be problematic, however, considering that clinically significant 
98 scores identified by questionnaires could be acquired in the absence of the core symptoms of 
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99 depression, and that clinically significant sum-scores do not require the presence of any 
100 specified number of symptoms (Fried & Nesse, 2015a). Consequently, on some screening 
101 tools such as the PHQ-9, it would be plausible for an athlete to report an elevated score 
102 merely on a single symptom, and still receive a clinically significant sum-score. In-fact, 
103 clinically significant scores could be attained by athletes who would not fulfil a single 
104 criterion for a diagnosis of MDD, if assessment would be performed via clinical 
105 interviews. Indeed, recent findings suggest that screening tools such as the PHQ-9 
106 significantly over-estimate rates of MDD (Levis et al., 2020). 
107 Considering the heterogeneity of depressive symptoms, there is also an inherent 
108 disadvantage in interpreting questionnaire data solely in relation to sum-scores, as they may 
109 mask important information of the underlying symptomology (Fried et al., 2014; Ingram et al., 
110 2015; Moriarity & Alloy, 2020). Consequently, the interpretation of findings could in some 
111 cases turn out to be “…as inadequate as the count of broken bones in a trauma victim” (Fried & 
112 Nesse, 2015a, pp., 6-7). This is, however, not to mean that sum-scores should not be applied or 
113 that they are not meaningful in research or practice, but rather, that there may be several 
114 opportunities over and beyond sum-scores that symptom-based assessment could offer. For 
115 example, while elevated depressive symptoms have shown to increase the risk for developing 
116 MDD over time (Ingram et al., 2015), experiencing issues with a specific depressive 
117 symptom, such as problems with sleep, can in itself be a significant source of distress and 
118 impairment for athletes (Moesch et al., 2018; Reardon et al., 2019; Roberts et al., 2016). 
119 Depressive symptoms may also vary in their impact on individuals’ psychosocial functioning, 
120 and can differ in their salience across different life domains (e.g. work and interpersonal 
121 relationships) (Fried et al., 2016; Fried & Nesse, 2014). There is also evidence suggesting that 
122 depressive symptoms may be differentially related to risk factors. Lux and Kendler (2010) for 
123 example observed that in a sample of individuals diagnosed with MDD, females were more 
124 likely to exhibit depressed mood, appetite/weight changes, and fatigue, while males were more 
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125 likely to exhibit psychomotor agitation/retardation. Furthermore, elevated symptoms of 
126 depressed mood and psychomotor agitation/retardation were related to older age. 
127 Despite the recent developments in research on depressive symptom prevalence and 
128 associated risk factors in athletes (Golding et al., 2020; Moesch et al., 2018; Reardon et al., 
129 2019; Wolanin et al., 2015), to our knowledge, previous studies have not explored the 
130 prevalence of the specific symptoms that may lie beneath summed symptom scores. We 
131 propose that exploring specific symptoms in addition to sum-scores offers an opportunity for 
132 establishing a richer understanding of the underlying issues that may be especially relevant 
133 in athletes. Exploring specific symptomology may also be especially fruitful as this “…may 
134 enable the development of personalized prevention that focuses on specific problems and 
135 symptoms before they transition into a full-fledged depressive episode” (Fried & Nesse, 2015b, 
136 p.4). Against this backdrop, in this preliminary investigation, we first aim to complement 
137 previous research by reporting the overall prevalence rates of depressive symptoms and 
138 compare these across age, sex, type of team sport, and level of competition. We also aim to 
139 extend current symptom-based research by 1) exploring the prevalence of the core symptoms 
140 of depression (i.e. depressed mood and lack of interest/pleasure) across different sum-score 
141 severity, and by identifying the number of additional symptoms exhibited by athletes with or 
142 without these core symptoms, and 2) by testing potential differences in the likelihood of 





148 The data for the current study were derived from a project exploring gambling 
149 behaviours in Icelandic athletes competing in football, basketball, and handball. Of the 
150 estimated population of Icelandic competitive adult athletes in these sports (N=3641), a total of 
151 1241 athletes (34.1%) participated in the research project. For the current study, however, only 
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152 athletes with valid responses to one or more depressive symptom items were included. 
153 Therefore, of the 1241 participants, 894 athletes (72.0%) were included in the current study 
154 (football=63.2%; basketball=100%; handball=70.5%). More specifically, the current sample 
155 for football represented 20.3% of the Icelandic football population (N=2170 across 105 teams) 
156 with a total of 441 participants included (age range 18-41 years, male 70.1%). For basketball, 
157 the sample represented 36.1% of the Icelandic basketball population (N=659 across 56 teams) 
158 with a total of 238 participants (age range 18-41 years, male 62.6%). For, handball, sample 
159 represented 26.5% of the Icelandic handball population (N=812 across 20 teams) with a total of 
160 215 participants (age range 18-42 years, male 51.2%). 
161
162 Measures
163 Depressive symptoms were assessed by the Patient Health Questionnaire 9 (PHQ – 9) 
164 (Kroenke & Spitzer, 2002), which assesses the presence of the nine depressive symptoms listed 
165 in DSM during the past two weeks: “little interest or pleasure doing things” (interest), “feeling 
166 down, depressed, or hopeless” (depressed mood), “trouble falling or staying asleep, or sleeping 
167 too much” (sleep), “feeling tired or having little energy” (fatigue), “poor appetite or 
168 overeating” (appetite), “feeling bad about yourself - or that you are a failure or have let 
169 yourself or your family down” (worthlessness/guilt), “trouble concentrating on things, such as 
170 reading the newspaper or watching television” (concentration), “moving or speaking so slowly 
171 that other people could have noticed? Or the opposite - being so fidgety or restless that you 
172 have been moving around a lot more than usual” (psychomotor), and “thoughts that you would 
173 be better off dead or of hurting yourself in some way” (suicidal thoughts) (Kroenke & Spitzer, 
174 2002). Each item is scored on a range from 0 to 3, where 0 = “not at all”, 1= “several days”, 2 
175 = “more than half the days”, and 3 = “nearly every day”, with sum-scores ranging from 0 to 
176 27. Kroenke and Spitzer (2002) suggested a cut-off score of ≥10 (at least moderate severity) for 
177 identifying individuals with clinically relevant symptoms. However, it has also been noted that 
178 it is important to report prevalence rates using different cut-off points to offer more valid 
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179 comparisons across studies (Manea et al., 2012). Considering the exploratory nature of the 
180 current study we report the prevalence of clinically significant symptoms utilizing cut-offs, 
181 ≥10 (at least moderate symptoms) and ≥15 (at least moderately severe symptoms) (Kroenke & 
182 Spitzer, 2002). Furthermore, the PHQ-9 scores can also be analysed using an algorithm 
183 method. As described by Manea et al. (2015), when using the algorithm method, clinical 
184 significance is determined based on the DSM criteria where at least five symptoms must be 
185 present (item scored ≥2, except for suicidal ideation scored ≥ 1)1, of which at least one must be 
186 depressed mood or lack of interest/anhedonia. The algorithm method has low sensitivity 
187 (increased risk for false-negatives) but shows excellent specificity (decreased likelihood of 
188 false-positives), while the sum-score method has shown to have more optimal trade-off 
189 between sensitivity and specificity (Manea et al., 2015). As the goal of questionnaires (or 
190 screening tools) is to overestimate true rates to minimize potential false-negative cases (failing 
191 to identify cases with the condition), the sum-score method has been more commonly utilized 
192 (Manea et al., 2015). However, as the aim of this study is to explore the underlying 
193 symptomology in more detail, we also explore prevalence rates using the algorithm method. 
194 The psychometric properties of PHQ-9 have shown to be good among the clinical (Kroenke & 
195 Spitzer, 2002) and the general populations (Martin et al., 2006), including the Icelandic 




200 In collaboration with the Icelandic national associations in football 
201 (Knattspyrnusamband Íslands, KSÍ), basketball (Körfuknattleikssamband Íslands), and 
202 handball (Handknattleikssamband Íslands, HSÍ), the general managers of all clubs in Iceland 
203 were contacted and requested to participate and to co-operate in recruiting gatekeepers 
1 When we report the overall prevalence of each symptom (see table 2), to make interpretations of the 
prevalences across symptoms comparable, a score ≥2 was used to identify symptom presence for all symptoms. 
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204 (coaches) from their respective clubs. Only one football club declined the invitation to 
205 participate in the study. Following approval for co-operation, a link to the questionnaire was 
206 sent to the gatekeepers within every team, who then shared the link with their players (age ≥18) 
207 and encouraged them to participate in the study. Gatekeepers were contacted approximately 2-
208 3 weeks following the initial contact, requesting them to remind the players about the study. 
209 All potential participants were informed that participation in the study was optional, responses 
210 on the questionnaire were anonymous, and that they could withdraw from the study at any 
211 point. Participants were also provided with contact information for psychological support and 
212 encouraged to seek help if they were experiencing any type of distress. Participants did not 
213 receive any form of compensation for their participation. Permission for the study was obtained 
214 from the National Bioethics Committee in Iceland (B20171100004 and S1512-00001) and the 
215 Icelandic Data Protection Authority.
216
217 Statistical Analyses
218 We utilized logistic regression models with adjusted odds ratios and 95% confidence 
219 intervals to test differences across two generic (sex and age), and two sport-specific (level of 
220 competition and type of team sport) variables on the odds of exhibiting specific depressive 
221 symptoms. 
222 Binary dependent variables (specific symptoms) were coded as “0” = not present and 
223 “1” = present. For eight symptoms the score of ≥2 (“more than half the days” or “nearly every 
224 day”) signified the presence of the symptom, however, for the 9th symptom “suicidal 
225 thoughts” a score of ≥1 (at least “several days”) implied the presence of the symptom (Lux & 
226 Kendler, 2010; Manea et al., 2015). We coded predictors as binary dummy variables with the 
227 reference category coded as “0” and each remaining level within the predictor as “1”. Each 
228 level (“1”) was then tested separately against the reference category (“0”). The reference group 
229 was chosen based on the literature when possible, such as that the reference category was 
230 assumed to exhibit the lowest levels of depressive symptoms. The reference categories across 
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231 predictive variables were; male (sex), older (age), and top-level (level of competition). As 
232 previous literature has not explored differences across the specific sports included in our study, 
233 football (type of team sport) was chosen as the reference group (lowest mean sum-score). Due 
234 to a low number of female athletes 27 and older – the older female group (reference category) 
235 included ages ≥24, while for males the reference group consisted of athletes ≥27 years old. 
236 The regression models for comparing male and female athletes across specific 
237 symptoms were adjusted for age, type of sport and level of competition, while the models 
238 comparing different sports were adjusted for sex, age, and level of competition. Analyses 
239 on sex differences within athletes with clinically significant scores (PHQ-9 ≥10) were, 
240 however, un-adjusted due to the low number of athletes in this sub-group (n=72). Models 
241 testing differences across age and level of competition were conducted separately for male 
242 and female athletes adjusting for the remaining predictors. 
243 Two participants had one missing value on the PHQ-9 scale (case 1, response on sleep 
244 missing, and case 2, response on concentration missing) but were included in the sum-score 
245 analyses by replacing the missing value with 0 (symptom not present). Results for sum-score 
246 and logistic regression analyses were tested with and without this correction and there were no 
247 notable differences in the outcome. Nine other cases had more than one missing item on the 
248 PHQ-9 scale and were therefore not included in the sum-score analyses. However, all cases 
249 with valid responses to specific items were included in the logistic regression analyses across 
250 specific symptoms. All analyses were conducted using the IBM SPSS version 25.0.
251
252 Results
253 Sum-score Means and Prevalence across determinants
254 The overall prevalence of clinically significant depressive symptoms in the sample 
255 (N=885) was 8.1 % and 2.7% when applying a cut-off score ≥10 and ≥ 15, respectively. As 
256 shown in Table 1, the corresponding prevalence rates when applying cut-offs ≥10 and ≥ 15, 
257 were 5.8% and 2.3% for male athletes (N=565), and 12.2% and 3.4% for female athletes 
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258 (N=320). Kruskall-Wallis test showed that female athletes had a significantly higher 
259 prevalence than male athletes when cut-off score 10 was applied [H(1) = 11.00, p = .001], 
260 however, no significant difference was observed when cut-off 15 was applied. In female 
261 athletes, Kruskall-Wallis test showed that prevalence (cut-off 10) was significantly different 
262 between age groups [H(4) = 11.55, p= .02], with 18-20-year-olds having significantly higher 
263 prevalence rate (19%) than 21-23-year-olds (8.3%, p= .02), 24-26 year-olds (6.3%, p= .20), 
264 and 27-29 year olds (3.8%, p=.03). When applying the cut-off score of 15, no significant 
265 differences were observed in female athletes across the predictive variables. Independent of 
266 the cut-off score used, there were no significant differences in prevalence rates across the 
267 predictive variables in male athletes. 
268 As also shown in table 1, female athletes had significantly higher mean symptom scores 
269 (M=5.11, SD= 4.38) than male athletes (M=3.05, SD=3.70) [t(575.17) = -7.10, p< .001]. In 
270 male athletes, the only mean depressive symptom score difference was found between type of 
271 sports [F(2, 562) = 4.04, p = .018], with Tukey post hoc test revealing a significantly higher 
272 score for male handball players (M=3.93, SD=3.82) than football players (M=2.77, SD=3.35) 
273 (p=.013). In female athletes, the only significant difference was found across age [F(4, 315) = 
274 3.90, p = .004], and according to Tukey post hoc test, this difference was significant between 
275 the youngest (18-20 year-old, M= 6.02, SD=4.63) and oldest athletes (30-42 year-old, M= 
276 2.80, SD=3.29) (p= .004).
277
278 Prevalence of Specific and Total Number of Symptoms
279 Table 2 shows the overall prevalence of the specific depressive symptoms in the 
280 sample, and among athletes with and without clinically significant sum-scores. Prevalence of 
281 specific symptoms for the whole sample ranged from 1.6 % for suicidal ideation to 12.2 % for 
282 fatigue. The core symptoms of depression, lack of interest and depressed mood, were present 
283 for most of the days in the past two weeks in 6.8% and 5.9% of the sample, respectively. 
284 Approximately half of the athletes with clinically significant sum-scores exhibited the core 
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285 symptoms of depression. In terms of the total number of symptoms (table 2), 75.7% of the 
286 sample did not exhibit any symptoms, and 16.3% exhibited 1-2 symptoms. Within athletes 
287 who had clinically significant scores, 51.4 % reported 3-4, and 38.9% five or more symptoms. 
288
289 Prevalence of Core Symptoms of Depression across Sum-score Severity
290 Table 3 illustrates the prevalence of the core symptoms (i.e. depressed mood and 
291 lack of interest/pleasure) across athletes with different sum-score severity. Of the male 
292 athletes with PHQ-9 sum-scores in the 10-14 range (moderate depressive symptoms, n=20), 
293 45% did not exhibit either of the core symptoms of depression. Of the male athletes with 
294 PHQ-9 scores in the 15-27 range (moderately severe to severe symptoms, n=13), 23.1% did 
295 not exhibit the core symptoms. In females, 53.6% of athletes within the 10-14 range (n=28) 
296 did not exhibit the core symptoms, while all female athletes within the 15-27 range (n=11) 
297 exhibited at least one of the core symptoms. Overall, 37.5% (27/72) of all athletes with 
298 clinically significant sum-scores (PHQ-9 ≥10) did not exhibit the core symptoms of depression. 
299 However, when the PHQ-9 cut-off ≥15 was applied, only 12.5% (3/24) of athletes with 
300 clinically significant scores did not exhibit the core symptoms.
301
302 Number of Additional Symptoms across Athletes with and without Core Symptoms of 
303 Depression
304 The total number of additional symptoms across athletes with or without the core 
305 symptoms of depression are presented in table 4. Of the athletes that did not exhibit the core 
306 symptoms of depression (n=813), the vast majority exhibited no other depressive symptoms 
307 (82.4%) or 1-2 symptoms (15.1%). Of those athletes that presented only lack of interest (n=20) 
308 or only depressed mood (n=11), two athletes (6.5%) exhibited 4 additional symptoms. Of the 
309 athletes presenting with both core symptoms of depression (n=39), 61.5% exhibited three or 
310 more additional symptoms. Hence, overall, 2.9 % (n=26) of athletes exhibited a total of five 
311 symptoms of which at least one was either depressed mood or lack of interest.
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312
313 Differences in the Odds of Experiencing Specific Depressive Symptoms across Selected 
314 Determinants 
315
316 Table 5 shows adjusted logistic regression models, for each depressive symptom across 
317 the selected determinants. Compared to male athletes, female athletes were significantly more 
318 likely to report depressed mood, sleep problems, fatigue, problems relating to appetite, 
319 feelings of worthlessness/guilt, and problems with concentration (controlling for the effects of 
320 age, level of competition, and type of sport). The highest odds for females in comparison to 
321 males was found in fatigue (OR=3.88, CI95%=2.37-6.37), depressed mood (OR=2.08, 
322 CI95%=1.91-3.97), and appetite-related issues (OR=2.08, CI95%= 1.15-3.74). When sex 
323 differences were explored among athletes with clinically significant sum-scores (PHQ-9 ≥10) 
324 (not included in table 5), female athletes showed significantly higher odds of fatigue 
325 (OR=6.60, CI95%=2.18-19.97), while males showed significantly higher odds of psychomotor 
326 issues (OR=.26, CI95%=.08 -.84) than females.
327 When football players were compared to players from the two other team sports, 
328 handball players had significantly higher odds of experiencing depressed mood, and issues 
329 with sleep and appetite, while basketball players showed higher odds of sleep and appetite-
330 related issues than football players (adjusting for sex, age, and level of competition). Most 
331 notably, the likelihood of experiencing appetite-related issues more than half the days in the 
332 past two weeks was more than four-fold (OR=4.31, CI95%= 2.03-9.18) in basketball players 
333 than in football players.
334 Due to sex-differences in the distribution of scores in age and level of competition, 
335 these variables were explored separately for male and female athletes. Models for age were 
336 adjusted for level of competition and type of sport, and models for the level of competition 
337 were adjusted for type of sport and age. As shown in Table 5, when male athletes 27 years and 
338 older were compared to the other age groups, 21-23- and 18-20-year-olds had significantly 
339 higher odds of exhibiting depressed mood and issues with sleep and appetite. Odds of 
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340 experiencing issues with appetite were notably high, with 21-23-year-olds showing almost 
341 five-fold (OR=4.90, CI95%=1.01-23.90), and 18-20-year-olds seven-fold increase in odds 
342 (OR=7.06, CI95%=1.52-32.79) when compared to male athletes 27 years and older. 
343 Furthermore, male athletes 18-20-years-old showed significantly higher odds of experiencing 
344 lack of interest than male athletes 27 years and older. Within female athletes, 18-20-year-olds 
345 showed significantly higher odds of exhibiting the core symptoms of depression (lack of 
346 interest and depressed mood) than female athletes 24 years and older. Female athletes 18-20-
347 years-old also had a higher likelihood of feeling worthlessness/guilt and having problems with 
348 concentration. In these comparisons the most notable difference was found in the likelihood of 
349 experiencing depressed mood, with the youngest female athletes having an almost five-fold 
350 increase in odds (OR=4.78, CI95%=1.37-16.65) compared to female athletes 24 years and 
351 older.
352 Concerning the level of competition, the only differences were observed between male 
353 top-level and male first division players. Male athletes competing in first division (second-
354 highest level) had significantly higher odds of experiencing worthlessness/guilt and 
355 psychomotor issues than top-level players. Most notably, first division players had more than 
356 a four-fold increase in odds (OR=4.50, CI95%=1.16-17.43) of experiencing psychomotor 
357 issues when compared to top-level players.
358
359 Discussion
360 In this preliminary investigation, we aimed to complement previous research by 
361 exploring the overall prevalence of depressive symptoms, and to test potential differences 
362 across generic and sport-specific determinants in a large representative sample of Icelandic 
363 team sport athletes. Additionally, to further extend knowledge-advancement in the field, we 
364 explored the prevalence of specific depressive symptoms, and tested potential within factor 
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365 differences (e.g. different age groups) in the odds of experiencing different types of 
366 depressive symptoms. 
367
368 Sum-score Means and Prevalence across Determinants
369 The overall prevalence of depressive symptoms in the sample was 8.1 % and 2.7% 
370 when applying a cut-off score ≥10 and ≥ 15, respectively. In comparison, Tahtinen and 
371 Kristjansdottir (2019) reported a 20.9% prevalence rate in Icelandic individual sport 
372 athletes using the PHQ-9 with a cut-off score of 10. This supports some previous findings 
373 which have suggested that elevated depressive symptoms may be more prevalent in individual 
374 sport athletes when compared to team sport athletes (Beable et al., 2017; Nixdorf et al., 2013, 
375 2016). Female athletes in our sample had a significantly higher prevalence of depressive 
376 symptoms than male athletes when a cut-off score of 10 was applied, which is in-line with 
377 previous findings on sex differences in athletes (Golding et al., 2020). However, no sex 
378 differences were observed when applying a cut-off score of 15, suggesting that while female 
379 athletes may be more likely than males to experience moderate levels of depressive symptoms, 
380 the rates of more severe symptomology may be comparable between the sexes. Within female 
381 athletes, the only significant mean differences emerged between younger and older athletes, 
382 and in male athletes, the only difference was found between different sports. This latter 
383 finding is somewhat surprising considering that football, handball, and basketball are all team 
384 ball sports in which the nature of competition (e.g. team-based with competition outcome 
385 evaluated objectively, i.e. scoring point/goals) and related stressors such as public evaluation 
386 of performance (Doherty et al., 2016), could be expected to be somewhat similar. We did not, 
387 however, assess other factors that could have explained the observed differences, such as injury 
388 or concussion (Rice et al., 2018) overtraining (Peluso & Andrade, 2005) or burnout (Gerber et 
389 al., 2018), which have all shown to relate to higher depressive symptoms. Nevertheless, our 
390 findings highlight that while the broader sports categories such as individual and team sports 
391 have shown to differ in rates of depressive symptoms (Beable et al., 2017; Nixdorf et al., 
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392 2016); there may also be important differences across different sports within these broader 
393 categories (Rice et al., 2016). In line with recent research (Golding et al., 2020; Junge & 
394 Feddermann-Demont, 2016; Junge & Prinz, 2018; Nixdorf et al., 2013; Wolanin et al., 2016), 
395 our study emphasizes the need for more fine-grained analyses across different sports to 
396 better understand factors that may contribute to elevated depressive symptoms in 
397 athletes.
398
399 Prevalence of Specific Symptomology 
400 In the current sample, the prevalence of specific depressive symptoms (symptom 
401 present at least most of the days in the past two weeks) ranged from 1.6 % for suicidal 
402 ideation to 12.2 % for fatigue. As shown in our data and previous research, fatigue (low 
403 energy/tiredness) is a common symptom in athletes (Birrer et al., 2013; Matos et al., 2011) and 
404 could therefore represent an important target for future prevention programs independent of the 
405 type of athletes the program is designed for. 
406 As most studies to-date have utilized questionnaires to assess depression in athletes – 
407 current knowledge of athletes’ susceptibility to major depressive disorder (MDD) is largely 
408 unknown (for a notable exception see Schaal et al., 2011). Nonetheless, research in athletes has 
409 tended to utilize the terms depression and depressive symptoms interchangeably when 
410 discussing clinically significant depressive symptom sum-scores, potentially clouding the 
411 meaning and interpretation of findings across studies (Schuch, 2015). One of the aims of this 
412 study was therefore to explore sum-scores from the perspective of DSM criteria. Several 
413 studies in athletes have utilized PHQ-9 scores ≥10 as a cut-off for identifying clinically 
414 relevant cases and reporting prevalence rates (Bell et al., 2016; Du Preez et al., 2017; McGuire 
415 et al., 2017; Silva-Rocha et al., 2019; Tahtinen et al., 2020; Tahtinen & Kristjansdottir, 2019). 
416 We, however, speculated that when applying this cut-off, athletes could attain clinically 
417 significant scores without exhibiting the core symptoms of depression (i.e. lack of interest 
418 and depressed mood). Indeed, we found that 37.5% of all athletes who had clinically 
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419 significant sum-scores (PHQ-9 ≥10) did not exhibit the core symptoms of depression. 
420 However, this was reduced to 12.5% among athletes with moderately severe to-severe sum-
421 scores (PHQ-9 ≥15). Furthermore, 45% of male and 53.6% of female athletes with moderate 
422 depressive symptoms (PHQ-9 scores 10-14) did not exhibit the core symptoms of depression. 
423 According to Kroenke et al. (2001), the PHQ-9 shows increasing specificity (decrease in 
424 potential false-positive cases) but attenuated sensitivity (increase in potential false-negative 
425 cases) as cut-off scores increase in the moderate depressive symptom range (scores 10-14) 
426 and hence, this range has also been identified as the “grey zone”. Considering that 
427 approximately half of the athletes scoring within the “grey zone” did not exhibit the core 
428 symptoms of depression - it could have been deemed misleading to report our findings 
429 concerning prevalence rates as the proportion of “depressed” athletes when applying the 
430 cut-off  ≥10. On the other hand, using a higher cut-off point could potentially lead to 
431 increased risk of missing “true” cases. Although we did not conduct diagnostic interviews 
432 to test the sensitivity and specificity of the PHQ-9 scale in our athlete sample, our findings 
433 provide new insights into the underlying symptomology in athletes with clinically 
434 significant sum-scores.
435 We also speculated that it would be plausible for an athlete to report an elevated 
436 score merely on a single symptom, and still receive a clinically significant sum-score. 
437 However, 90% of athletes who had clinically significant depressive symptoms exhibited at 
438 least three symptoms. To further understand clinically significant symptoms in our sample, we 
439 applied an algorithm method to explore the number of athletes that self-reportedly fulfilled the 
440 DSM criteria for exhibiting a minimum of five symptoms, of which at least one symptom was 
441 either depressed mood or lack of interest. We found that overall, 2.9% of athletes self-reported 
442 meeting these criteria, which is considerably lower than the 8.1% prevalence observed when 
443 cut-off score 10 was applied, and closer to the prevalence rate obtained by a cut-off 15 (2.7%). 
444 This is also similar to the 3.6% prevalence reported in a study among French elite athletes 
445 who were assessed using semi-structured diagnostic interviews (Schaal et al., 2011). We 
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446 only know of one study to-date that has reported prevalence rates in athletes using both self-
447 report questionnaires and clinical interviews. In their study, Hammond et al. (2013) found that 
448 34% of elite swimmers met DSM criteria for a major depressive episode when assessed by 
449 clinical consultations, while 22% reported mild and only 4 % moderate levels of depressive 
450 symptoms when assessed by the Beck’s Depression Inventory-II (BDI-II). Considering that 
451 screening tools are designed to over-estimate true cases (Manea et al., 2015), finding a higher 
452 number of cases by clinical interviews than questionnaires is surprising. It has, however, been 
453 underlined that the optimal cut-off score may depend on the setting in which assessment 
454 is conducted, that is, the same cut-off score can result in many false-positives in one 
455 setting, while leading to more false-negatives in another (Manea et al., 2012). Hence, 
456 considering the findings in the current study and those reported by Hammond and 
457 colleagues (2013), future studies are needed to validate existing screening tools in the 
458 athlete populations.
459
460 Differences in the Odds of Experiencing Specific Depressive Symptoms across Selected 
461 Determinants 
462
463 When compared to male athletes, female athletes showed significantly higher odds of 
464 exhibiting depressed mood, sleep problems, fatigue, problems relating to appetite, feelings of 
465 worthlessness/guilt, and problems with concentration. Furthermore, we found that among 
466 athletes with clinically significant sum-scores, females were more likely than males to 
467 experience fatigue, while males were more likely to experience psychomotor issues. Our 
468 findings are in-line with those reported by Lux and Kendler (2010), where females diagnosed 
469 with MDD were more likely than males to exhibit depressed mood, appetite/weight changes 
470 and fatigue, while males were more likely to experience psychomotor issues. Our symptom-
471 specific analyses extend current knowledge and suggests that the higher overall depressive 
472 symptom severity identified in females is reflected in several specific symptoms. It is 
473 interesting to note, however, that while the key symptoms differing within the male sample 
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474 were related to neurovegetative symptoms (sleep and appetite), within female athletes, 
475 variability was more prominent in cognitive symptoms. For example, when compared to older 
476 female athletes the youngest female athletes in our sample had significantly higher odds of 
477 exhibiting a lack of interest, depressed mood, worthlessness/guilt, as well as concentration 
478 problems. Most notably, younger female athletes (18-20 years) had almost a five-fold increase 
479 in odds of experiencing depressed mood compared to female athletes 24 years and older. 
480 Relatively few studies in athletes have, however, explored depression, or other mental health 
481 issues, specifically in female athletes (Golding et al., 2020; Küttel & Larsen, 2019). 
482 Considering that female athletes exhibited higher prevalence rates across several specific 
483 symptoms when compared to male athletes, attention in future research, prevention, and 
484 applied efforts should be directed at this population. Furthermore, although sex differences 
485 have been noted in previous research, there is a gap in our knowledge concerning the factors 
486 that could potentially explain these differences. In this context, and as has been voiced by 
487 Nixdorf et al. (2020), future research could benefit from exploring cognitive mechanisms 
488 to identify factors that may be especially relevant for targeted prevention and treatment 
489 among in-risk athletes. 
490 While our sum-score analyses identified overall differences between football players 
491 and handball players, symptom specific analyses revealed additional findings. Both handball 
492 and basketball players were more likely to report issues with sleep and appetite in comparison 
493 to football players. Also, handball players were more likely than football players to report 
494 experiencing depressed mood. Depressed mood, and issues with sleep and appetite were also 
495 the key symptoms in males when age differences were compared between older and younger 
496 athletes. The odds of experiencing issues with appetite were notably high, with 21-23-year-old 
497 males showing almost five-fold, and 18-20-year-olds a seven-fold increase in odds compared 
498 to male athletes 27 years or older. While it is difficult to speculate as to why we found these 
499 differences, regulation of sleep and appetite has shown to be related to similar biomarkers 
500 among depressed patients (Caroleo et al., 2019). Based on our findings these specific 
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501 symptoms could provide an interesting avenue for further research in depression-related 
502 research in athletes.
503 Level of competition did not contribute to differences in across depressive symptoms 
504 within female athletes. Considering that our adjusted analyses demonstrated more variability 
505 across age than the level of competition, the higher susceptibility of lower-level athletes found 
506 in previous studies (Junge & Feddermann-Demont, 2016; Junge & Prinz, 2018; Nixdorf et al., 
507 2013) may be better explained by age-related differences. Nevertheless, while controlling for 
508 the effects of age and type of sport, we found that male athletes competing in first division 
509 (second-highest level) had significantly higher odds of experiencing worthlessness/guilt and 
510 psychomotor issues than top-level players. While the findings concerning differences in 
511 psychomotor issues may be difficult to interpret, the observed difference in 
512 worthlessness/guilt could perhaps be understood through the lens of athletic identity (Brewer & 
513 Petitpas, 2017). As there may be similar physical and psychosocial demands (e.g. training and 
514 competition load) for first division and top-league players in Iceland, a strong identification 
515 with the athlete role may be comparable between these groups. However, the threats to athletic 
516 identity may be more pronounced for the first division players as the sport career prospects 
517 may be less secure than for the top-level players. 
518 Overall, our exploratory findings highlight the importance of applying an analysis 
519 of the underlying symptomology in parallel to reporting sum-scores when assessing 
520 depressive symptoms in athletes. If findings are interpreted only in terms of summed 
521 scores, important information may be lost, and interpretations may have limited utility in 
522 terms of knowledge advancement in the field. Applying a more detailed exploration of the 
523 underlying symptomology could also generate useful information for more theory-driven 
524 approaches to understanding depression and depressive symptoms in athletes – and 
525 therefore, the development of more targeted and tailor-made approaches to intervention 
526 in the future (Nixdorf et al., 2020). As noted by Purcell et al. (2019), it is also important to 
527 understand athlete mental health from a broader ecological perspective. We propose that 
Page 20 of 37
http://mc.manuscriptcentral.com/hk_jcsp
Journal of Clinical Sport Psychology
For Peer Review
528 exploring individual symptoms, rather than only sum-scores, could significantly 
529 contribute to this understanding in future research. For example, by providing more 
530 detailed information about the specific symptoms that may be especially prevalent in 
531 different athlete populations, future research could more systematically map the relevant 
532 contextual risk factors that may contribute to these symptoms.
533  
534 Clinical Implications
535 Service provision for athletes can vary largely across different sport settings 
536 (Kroshus, 2016; Moesch et al., 2018). In Iceland there are currently no systematic 
537 protocols in place for the assessment or treatment of mental health issues in athletes. 
538 However, as the current and previous findings (e.g. Kristjánsdóttir et al., 2019; Tahtinen 
539 & Kristjansdottir, 2019) suggest, more systematic approaches to providing mental health 
540 support among the Icelandic athlete population may be warranted. 
541 While systematic screening of depressive symptoms has been highlighted as an 
542 important objective for identifying and supporting in-risk athletes (Donohue et al., 2019; 
543 Wolanin et al., 2016), “routine” screening has also been questioned. Particularly, the 
544 potentially high number of false-positive cases identified by screening tools could lead to 
545 adverse consequences, such as over-diagnosis of depression, and increased risk of 
546 labelling and stigma among individuals screened with elevated symptom scores (He et al., 
547 2020; Joffres et al., 2013; Mojtabai, 2017). This may be especially relevant in athletes 
548 considering that screening tools have not yet been properly validated in this population 
549 (Moesch et al., 2018). As shown in our study, while 90% of athletes with clinically 
550 significant sum-scores exhibited at least three different depressive symptoms, almost 40% 
551 of athletes with moderate symptom severity (clinically significant score 10-14), did not 
552 exhibit the core symptoms of depression (depressed mood and lack of interest). 
553 If systematic screening is conducted in settings where there is already a suitable 
554 support infrastructure in place, it is important to determine which screening tool(s) and 
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555 cut-off score is utilized to identify athletes for a follow-up (Trojian, 2016). Considering 
556 that screening tools are designed to overestimate “true” clinical cases to minimize 
557 potential false-negative cases - rather than merely "red -flagging" athletes with clinically 
558 significant depressive symptom scores - exploring the specific symptomology could 
559 potentially improve the specificity of the screening results. For example, analysing scores 
560 specifically for symptoms such as depressed mood and/or lack of interest, insomnia or 
561 suicidal thoughts may be important when considering further follow-up (Joffres et al., 
562 2013). Furthermore, it is important to determine how initial screening results are 
563 communicated to athletes, and that athletes are included in the process when determining 
564 potential mental health referrals (Donohue et al., 2018; Joffres et al., 2013; Trojian, 
565 2016). Considering our findings, discussing specific symptoms and related issues that are 
566 especially relevant for athletes could potentially improve this decision-making process.
567 As shown in a study by Kroshus (2016) there were on average one full-time 
568 physician for each NCAA division I sports medicine department, and 376.4 student-
569 athletes per physician. Applying the 23.7% prevalence rate reported in college athletes by 
570 Wolanin et al. (2016) and the average number of students per physician reported by 
571 Kroshus (2016), at any given time there would be approximately 89 NCAA division I 
572 collegiate athletes per physician screened with clinically significant depressive symptoms. 
573 This underlines the importance of conducting an evidence-based assessment of the target 
574 population, and the resources required to assure that appropriate follow-up assessment 
575 and mental health support can be provided to athletes following the screening process. It 
576 must however be noted that our aim with this discussion is not to recommend for or 
577 against screening in athletes, but to highlight the potential utility of exploring individual 
578 depressive symptoms in settings where screening protocols are being planned or already 
579 in place.  
580 In our sample, 17% (n=138) of athletes with non-clinically significant depressive 
581 symptom sum-scores, reported experiencing 1-2 depressive symptoms most of the days in 
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582 the past two weeks. It is therefore important for practitioners working with athletes to be 
583 mindful of the possibility that although an athlete does not present with clinically 
584 significant depressive symptom sum-scores, they may nevertheless experience significant 
585 distress and impairment in specific areas of functioning (e.g. issues with sleep/appetite, 
586 feelings of guilt). Therefore, independent of the sum-scores, it may be beneficial to discuss 
587 with the athlete about the individual symptoms on which they may exhibit elevated 
588 scores. This could also open new doors to identifying other potential mental health issues 
589 (Mummery, 2005; Trojian, 2016). For example, there is considerable overlap between 
590 symptoms of depression and other conditions highly relevant in the athlete population, 
591 such as overtraining syndrome (OTS) (Kreher, 2016), burnout (Nixdorf et al., 2020), and 
592 eating disorders (Kristjánsdóttir et al., 2019) and hence, a detailed analysis of the specific 
593 symptomology may provide the practitioner with additional road signs when 
594 conceptualizing potential issues that may need further assessment. 
595 One of the interesting and perhaps surprising, findings in our study was that there 
596 were significant differences in the mean sum-scores and the prevalence of specific 
597 symptoms between the three team sports included in our study. This suggests that even 
598 across sports that could be considered similar in terms of the nature of the competition 
599 (e.g. team-based with competition outcome evaluated objectively, i.e. scoring point/goals) 
600 – there may be important contextual differences influencing athletes’ mental health (Rice 
601 et al., 2016). Therefore, practitioners working in team-based settings could benefit from 
602 exploring specific symptoms to gain clues to the potential contextual factors that could 
603 undermine athletes’ well-being and performance. For example, if issues with sleep seem 
604 to be highly prevalent in the team or within the organization, the practitioner could map 
605 potential risk factors (e.g. training times, logistic issues in relation to traveling etc.), and 
606 consequently plan targeted interventions to address these issues. 
607
608
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609 Limitations and Future Directions
610 Some limitations to the current study should be noted. Firstly, the mean difference 
611 analyses did not consider potential differences emanating from unmeasured third variables and 
612 therefore, these unadjusted mean differences should be interpreted with this limitation in mind. 
613 This study was also cross-sectional and can only be considered descriptive of prevalence at one 
614 point in time. There is now evidence suggesting that prevalence rates may vary over a 
615 competitive season (Du Preez et al., 2017; McGuire et al., 2017) and hence, the reported rates 
616 should not be considered static. Furthermore, although we had large sample sizes across the 
617 included sports – almost 40% of football players and 30 % of handball players did not respond 
618 to the depression symptom items, and where therefore excluded from the current study. 
619 Consequently, the representativeness of our findings should be interpreted with this limitation 
620 in mind. In terms of our logistic regression analyses, the overall rates for some symptoms (e.g. 
621 psychomotor) were low, which may have biased the odds ratio estimates. Furthermore, it 
622 should be noted that several of the PHQ-9 items do not make a distinction between the 
623 direction of symptom presentation (e.g. eating too little or over-eating, sleeping too much/too 
624 little). Hence, we were not able to identify the exact nature of the issue relating to this 
625 symptom. 
626 Despite the limitations our study offers an important addition to previous depression-
627 related research in athletes. We utilized a large representative sample of team sport athletes 
628 from three popular team sports in Iceland. We also had sufficiently large sub-samples across 
629 the different sport and non-sport specific determinants, allowing us to conduct more specific 
630 (adjusted) analyses across these determinants. Our approach to exploring the prevalence of 
631 specific depressive symptoms was also novel in the athlete literature. Future research could 
632 take our analyses further and explore how different symptoms may relate to athlete 
633 functioning, in and out of sport, and explore these relations within prospective research 
634 designs. For example, in non-athletes, sad mood and concentration difficulties was shown to 
635 have the most severe influence on overall psychosocial functioning, whereas insomnia had a 
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636 strong influence on work life, self-blame on close relationships and loss of interest on social 
637 activities (Fried & Nesse, 2014).  
638
639 Conclusions
640 While research in athletes often note that depression questionnaires are limited in their 
641 ability to provide a depression diagnosis, few have explored the opportunities that 
642 questionnaires can offer, over and beyond the more commonly utilized sum-scores. As our 
643 study shows, there is a wealth of information to be gleaned by analysing the specific symptoms 
644 of depression. The initial findings suggest that female athletes report more symptoms than 
645 male athletes. Younger female athletes (18-20 years) in comparison to older (24+) may be 
646 especially prone to exhibit cognitive symptoms of depression, while younger male athletes (18-
647 20) in comparison to older males (27+) may be especially prone to experiencing issues with 
648 sleep and appetite. Our study also shows that when utilizing PHQ-9 cut-off 10 to identify 
649 clinically significant depressive symptoms, almost 40% of the identified cases did not exhibit 
650 depressed mood or lack of interest. Hence, referring to athletes with clinically significant 
651 depressive symptoms as “depressed” athletes, could have been misleading in the current study. 
652 It is, however, important to underline that 90% of athletes with clinically significant symptoms 
653 reported having experienced at least 3 different depressive symptoms most of the days in the 
654 past two weeks. Hence, although some athletes in this group did not experience the core 
655 symptoms of depression, they may have nevertheless experienced significant distress. With 
656 these considerations in mind, future studies are encouraged to further explore individual 
657 symptoms in addition to sum-scores, and to explore symptoms in relation to athletes’ overall 
658 psychosocial functioning. 
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Table 1
Sex Specific Sum-score Means and Prevalence Rates across Age, Competition Level, and Type of Sport
Sum-scores (male athletes) Sum-scores (female athletes)
Severity (cut-off) Severity (cut-off)
10-27 (≥10) 15-27 (≥15) 10-27 (≥10) 15-27 (≥15)
Factor N M SD n % n % N M SD n % n %
Total sample score 565 3.05 3.70 33 5.8 13 2.30 320 5.11 4.38 39 12.2 11 3.4
Age
    18-20 143 3.03 3.79 10 7.0 2 1.4 142 6.02 4.63 27 19.0 6 4.2
    21-23 146 3.47 4.02 10 6.8 5 3.4 84 4.68 4.14 7 8.3 3 3.6
    24-26 117 2.91 3.83 7 6.0 4 3.4 48 4.81 4.56 3 6.3 2 4.2
    27-29 76 2.61 3.20 2 2.6 1 1.3 26 3.81 2.82 1 3.8 0 .0
    30-42 83 2.94 3.13 4 4.8 1 1.2 20 2.80 3.29 1 5.0 0 .0
Competition level
    Top level 179 2.97 3.67 8 4.5 3 1.7 142 4.73 4.36 16 11.3 4 2.8
    1st division 117 3.51 4.13 10 6.8 4 3.4 178 5.41 4.38 23 12.9 7 3.9
    2nd division 86 2.70 3.08 5 5.8 0 .0 - - - - - -
    3rd division 72 2.74 4.00 3 4.2 0 .0 - - - - - -
    4th division 111 3.16 4.04 7 6.3 6 5.4 - - - - - -
Type of sport
    Handball 109 3.93 3.82 9 8.3 3 2.8 103 5.42 3.65 13 12.6 1 1.0
    Basketball 149 2.99 4.18 11 7.4 4 2.7 89 5.52 5.54 14 15.7 7 7.9
    Football (soccer) 307 2.77 3.35 13 4.2 6 2.0 128 4.57 3.97 12 9.4 3 2.3
Note. Sum-scores 10-27 = Moderate-severe, 15-27 = Moderately severe-severe. N = total number of athletes within factor level, n=number of athletes within 
severity. Scores ≥ 10 considered clinically significant according to Kroenke & Spitzer (2002). Levels 2nd -4th division includes only male athletes. Third 
division includes only male basketball and football players and 4th division includes only male football players. Bold numbers significant p< .05.
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Table 2
Prevalence of Individual Depressive Symptoms for the Sample and for Athletes with and without 
Clinically Significant Sum-scores
Symptom sum-score
Total sample ≤ 9 (N=813) ≥10 (N=72)
Factor N/n % % %
Type of symptom
    lack of interest 894/61 6.8 2.3 55.6
    Depressed mood 892/53 5.9 1.6 51.4
    Sleep problems 894/71 7.9 3.9 51.4
    Fatigue 894/109 12.2 6.9 66.7
    Problems with appetite 894/62 6.9 2.0 59.7
    Worthlessness/ Guilt 894/76 8.5 3.4 63.9
    Concentration problems 894/58 6.5 2.5 50.0
    Psychomotor problems 892/26 2.9 1.0 23.6
    Suicidal thoughts 888/14 1.6 .0 19.4
Number of Symptoms
    None 885/670 75.7 82.4 .0
    1-2 885/144 16.3 16.9 9.7
    3-4 885/43 4.9 .7 51.4
    ≥ 5 885/28 3.2 .0 38.9
Note. N/n=total number of athletes/athletes xhibiting symptom. All symptoms scored 0-3. 
Symptoms considered present if scored ≥ 2 (“more than half the days” or “nearly every day”). 
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Table 3
Prevalence of the Core Symptoms of Depression across Sum-score Severity
Severity sum-score (male) Severity sum-score (female)
0-9 (N=532) 10-14 (N=20) 15-27 (N=13) 0-9 (N=281) 10-14 (N=28) 15-27 (N=11)
Factor n % n % n % n % n % n %
Presence of defining 
symptoms
    Neither 519 97.6 9 45.0 3 23.1 269 95.7 15 53.6 0 .0
    Only decreased interest 8 1.5 4 20.0 0 .0 4 1.4 4 14.3 0 .0
    Only depressed mood 2 .4 2 10.0 0 .0 4 1.4 2 7.1 1 9.1
    Both symptoms 3 .6 5 25.0 10 76.9 4 1.4 7 25.0 10 90.9
Note. Sum scores 0-9=Minimal-mild, 10-14=Moderate, 15-27=Moderately severe-severe. N/n=Total number of athletes within severity 
category/number of athletes within factor. Scores ≥2 (“more than half the days” or “nearly every day”) indicating the presence of the core 
symptom. Highlighted cases represent athletes with clinically significant symptoms (PHQ-9 ≥ 10), without exhibiting the symptoms depressed 
mood and lack of interest.
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Table 4
Number of Additional Symptoms across Athletes without and with the Core Symptoms of Depression
Number of additional symptoms (excluding decreased interest and depressed mood)
0 1 2 3 ≥ 4
Factor n % n % n % n % n %
Presence of defining symptoms 
    Neither (N=815) 670 82.4 96 11.8 28 3.4 14 1.7 7 .9
    Only decreased interest (N=20) 7 35.0 5 25.0 3 15.0 4 20.0 1 5.0
    Only depressed mood (N=11) 1 9.1 4 36.4 4 36.4 1 9.1 1 9.1
    Both symptoms (N=39) 3 7.7 4 10.3 8 20.5 6 15.4 18 46.2
Note. N/n=Total number of athletes within factor/frequency of athletes exhibiting number of symptoms. Scores ≥2 (“more than half 
the days” or “nearly every day”) indicating the presence of a symptom (for suicidal ideation scores ≥ 1 “several days” or higher 
indicated presence). Highlighted cases identified as clinically significant based on the algorithm method (Manea et al., 2015).
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Table 5 
Binary Logistic Regression Models with Odds Ratios and 95% Confidence Intervals of Different Symptoms across Selected Determinants
Interest
Depressed 






    Female OR (n) 1.44 (894) 2.08 (892) 1.92 (894) 3.88 (894) 2.08 (894) 1.78 (894) 1.85 (894) .63 (892) 1.23 (888)
CI .80-2.60 1.91-3.97 1.07-3.46 2.37-6.37 1.15-3.74 1.04-3.04 1.01-3.41 .24-1.63 .69-2.20
Type of sport (reference football)
    Handball OR (n) 1.15 (656) 2.43 (654) 3.34 (656) 1.53 (656) 3.69 1.33 (656) 1.76 (656) 1.69 (654) 1.05 (650)
CI .57-2.34 1.08-5.46 1.57-7.12 .88-2.67 1.57-8.76 .68-2.62 .83-3.73 .56-5.11 .51-2.13
    Basketball OR (n) .98 (679) 2.11 (677) 2.19 (679) 1.47 (679) 4.31 (679) 1.67 (679) 1.54 (679) .81 (678) .90 (675)
CI .48-1.99 .96-4.67 1.07-4.50 .84-2.58 2.03-9.18 .88-3.14 .74-3.20 .25-2.61 .45-1.79
Sex-specific analyses
Age (male) (reference ≥ 27 years)
    24-26 years OR (n) 1.92 (277) 1.61 (277) 1.90 (277) 2.70 (277) 3.27 (277) 2.17 (277) 1.55 (277) 3.41 (277) 1.54 (276)
CI .58-6.31 .39-6.73  .65-5.54 .95-7.67 .57-18.75 .77-6.15 .52-4.62 .81-14.28 .54-4.44
    21-23 years OR (n) 2.16 (306) 3.52 (306) 2.93 (305) 2.37 (306) 4.90 (306) 2.40 (306) .96 (305) 2.33 (306) 1.98 (305)
CI .67-6.95 1.02-12.14 1.11-7.73 .84-6.71 1.01-23.90 .91-6.32 .31-2.95 .56-9.63 .74-5.26
    18-20 years OR (n) 3.03 (303) 2.07 (303) 1.70 (302) 1.99 (303) 7.06 (303) 1.59 (303) 1.26 (302) 1.53 (303) 1.66 (302)
CI 1.01-9.07 .58-7.43 .58-5.00 .69-5.74 1.52-32.79 .56-4.55 .44-3.62 .32-7.27 .60-4.56
Age (female) (reference ≥ 24 years)
    21-23 years OR (n) 2.00 (179) 2.35 (179) .61 (179) 1.62 (179) 1.83 (179) 2.76 (179) 1.48 (179) 0.00 (178) 1.11 (179)
CI .55-7.23 .56-9.85 .43-4.19 .75-3.50 .62-5.42 .91-8.35 .38-5.73 0.00 - .31-4.01
    18-20 years OR (n) 3.16 (241) 4.78 (239) 2.22 (241) 1.92 (241) 2.37 (241) 3.09 (241) 3.67 (241) 4.14 (240) 2.30 (238)
CI 1.04-9.67 1.37-16.65 .85-5.78 .97-3.82 .92-6.15 1.12-8.47 1.22-11.09 .49-35.04 .81-6.50
Level (male) (reference top level)
    1st division OR (n) 1.24 (297) 2.29 (297) 2.11 (297) 1.42 (297) 2.79 (297) 2.50 (297) .77 (297) 4.50 (297) 1.95 (296)
CI .47-3.28 .75-6.98 .80-5.57 .58-3.48 .98-8.00 1.02-6.15 .26-2.34 1.16-17.43 .78-4.88
    2nd – 4th division OR (n) .95 (450) .85 (450) 2.50 (450) .89 (450) 1.52 (450) 1.17 (450) .90 (450) 1.89 (450) .81 (448)
CI .33-2.72 .24-2.99 .85-7.31 .34-2.37 .40-5.70 .41-3.36 .31-2.61 .35-10.12 .30-2.19
Level (female) (reference top level)
     1st division OR (n) .76 (326) .87 (324) 1.83 (326) 1.49 (326) 1.07 (326) 1.07 (326) 1.26 (326) .50 (324) 1.68 (323)
CI .35-1.68 .40-1.91 .84-3.98 .86-2.59 .53-2.22 .53-2.17 .58-2.77 .11-2.37 .72-3.92
Note. Each symptom measured on a scale 0-3 with scores ≥ 2 indicating presence of the symptom. For suicidal thoughts scores ≥1 indicated the presence of the symptom. Bold numbers 
significant p< .05.
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